France’s Medical Cannabis Trial Receives Another Extension

Health authorities in France recently announced that the nation’s medical cannabis trial experiment will be extended until July 31st, 2025. The announcement is welcomed news to the reported 1,800 suffering patients estimated to be currently participating in the trial.

“The experiement was due to end on 31 December 2024, but at a meeting on Thursday between patient associations and the health authorities, the Ministry of Health gave the green light for it to run for a further six months, FranceInfo reported.” stated RFI in its local coverage.

“The extension will be granted only “with a view to weaning patients off the drug or finding alternatives”, the resigning Health Minister, Geneviève Darrieussecq, wrote in the letter enabling the decision.” the outlet also reported.

In March 2021, France launched its limited medical cannabis experiment involving between 2,000 and 3,000 suffering patients at the time to gain insight into crafting national medical cannabis policies and regulations.

The French medical cannabis experiment received initial approval from the federal Senate back in 2019, however, the launch of the trial was delayed until the spring of 2021 due to various reasons.

Initially slated for two years, France’s medical cannabis experiment was eventually granted a one-year extension and was set to end in 2024 before receiving the latest extension pushing the estimated end of the trial to the summer of 2025.

According to a recent newsletter sent out by international cannabis economist Beau Whitney of Whitney Economics, France is home to the largest total addressable cannabis market in the European Union with a value of $11.3 billion (midpoint).